2,220
Views
89
CrossRef citations to date
0
Altmetric
Clinical

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

, , , , , , , , , , , , , , , , , & show all
Pages 285-294 | Received 13 Jan 2014, Accepted 15 Jun 2014, Published online: 21 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (14)

Maryam Chaudhry, Paul Lyon, Constantin Coussios & Robert Carlisle. (2022) Thermosensitive liposomes: a promising step toward localised chemotherapy. Expert Opinion on Drug Delivery 19:8, pages 899-912.
Read now
Daphne Schouten, Rob van Os, Anneke M. Westermann, Hans Crezee, Geertjan van Tienhoven, M. Willemijn Kolff & Adriaan D. Bins. (2022) A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area. Acta Oncologica 61:4, pages 441-448.
Read now
Luisa L. Palmese, Ming Fan, Rebecca A. Scott, Huaping Tan & Kristi L. Kiick. (2021) Multi-stimuli-responsive, liposome-crosslinked poly(ethylene glycol) hydrogels for drug delivery. Journal of Biomaterials Science, Polymer Edition 32:5, pages 635-656.
Read now
Muhammad Zubair, Matthew S. Adams & Chris J. Diederich. (2021) Deployable ultrasound applicators for endoluminal delivery of volumetric hyperthermia. International Journal of Hyperthermia 38:1, pages 1188-1204.
Read now
Bingbing Cheng, Chenchen Bing, Robert M. Staruch, Sumbul Shaikh, Michelle Wodzak Staruch, Debra Szczepanski, Noelle S. Williams, Theodore W. Laetsch & Rajiv Chopra. (2020) The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes. International Journal of Hyperthermia 37:1, pages 1052-1059.
Read now
Anjan Motamarry, Ayele H. Negussie, Christian Rossmann, James Small, A. Marissa Wolfe, Bradford J. Wood & Dieter Haemmerich. (2019) Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes. International Journal of Hyperthermia 36:1, pages 816-825.
Read now
Or Perlman, Iris S. Weitz & Haim Azhari. (2018) Target visualisation and microwave hyperthermia monitoring using nanoparticle-enhanced transmission ultrasound (NETUS). International Journal of Hyperthermia 34:6, pages 773-785.
Read now
Sania Naz, Hira Shahzad, Attarad Ali & Muhammad Zia. (2018) Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment. Artificial Cells, Nanomedicine, and Biotechnology 46:5, pages 899-916.
Read now
Katja Zimmermann, Martin Hossann, Johannes Hirschberger, Karin Troedson, Michael Peller, Moritz Schneider, Andreas Brühschwein, Andrea Meyer-Lindenberg, Gerhard Wess, Melanie Wergin, René Dörfelt, Thomas Knösel, Markus Schwaiger, Christine Baumgartner, Johanna Brandl, Sabine Schwamberger & Lars H. Lindner. (2017) A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma. International Journal of Hyperthermia 33:2, pages 178-190.
Read now
Antoine G. van der Heijden & Mark W. Dewhirst. (2016) Effects of hyperthermia in neutralising mechanisms of drug resistance in non-muscle-invasive bladder cancer. International Journal of Hyperthermia 32:4, pages 434-445.
Read now
Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Vladimir V. Kosterev, Evgeny A. Kramer-Ageev, Vladimir N. Mazokhin, Gerard C. van Rhoon & Johannes Crezee. (2015) Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating. International Journal of Hyperthermia 31:4, pages 443-452.
Read now
Robert M. Staruch, Kullervo Hynynen & Rajiv Chopra. (2015) Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: Therapeutic effect in rabbit Vx2 tumours. International Journal of Hyperthermia 31:2, pages 118-133.
Read now

Articles from other publishers (75)

G. Adabbo, A. Andreozzi, M. Iasiello & G.P. Vanoli. (2024) Numerical evaluation of heat-triggered drug release via thermo-sensitive liposomes: A comparison between image-based vascularized tumor and volume-averaged porous media models. International Journal of Heat and Mass Transfer 220, pages 124942.
Crossref
G. Adabbo, A. Andreozzi, M. Iasiello, P.A. Netti & G.P. Vanoli. (2023) A 3D numerical model of controlled drug delivery to solid tumor by means of mild microwave hyperthermia-activated thermo-sensitive liposomes. International Journal of Thermal Sciences 193, pages 108528.
Crossref
Isidore A. Egebe & Kamalinder K. Singh. 2023. Drug and Therapy Development for Triple Negative Breast Cancer. Drug and Therapy Development for Triple Negative Breast Cancer 249 272 .
Prithwish Kola, Prasanth Kumar Bhusetty Nagesh, Pritam Kumar Roy, K. Deepak, Rui Luis Reis, Subhas C. Kundu & Mahitosh Mandal. (2023) Innovative nanotheranostics: Smart nanoparticles based approach to overcome breast cancer stem cells mediated chemo‐ and radioresistances. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Rumiana Tenchov, Janet M. Sasso & Qiongqiong Angela Zhou. (2023) PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective. Bioconjugate Chemistry 34:6, pages 941-960.
Crossref
Kenan Aloss & Peter Hamar. (2023) Recent Preclinical and Clinical Progress in Liposomal Doxorubicin. Pharmaceutics 15:3, pages 893.
Crossref
Farshad Moradi Kashkooli, Anshuman Jakhmola, Tyler K. Hornsby, Jahangir (Jahan) Tavakkoli & Michael C. Kolios. (2023) Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions. Journal of Controlled Release 355, pages 552-578.
Crossref
Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2023) Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. Cancer Letters 556, pages 216066.
Crossref
Dieter Haemmerich, Krishna K. Ramajayam & Danforth A. Newton. (2023) Review of the Delivery Kinetics of Thermosensitive Liposomes. Cancers 15:2, pages 398.
Crossref
Hsin Chan, Hsin-Yun Chang, Win-Li Lin & Gin-Shin Chen. (2022) Large-Volume Focused-Ultrasound Mild Hyperthermia for Improving Blood-Brain Tumor Barrier Permeability Application. Pharmaceutics 14:10, pages 2012.
Crossref
Lesley Cheng & Andrew F. Hill. (2022) Therapeutically harnessing extracellular vesicles. Nature Reviews Drug Discovery 21:5, pages 379-399.
Crossref
Mayumi Ikeda-Imafuku, Lily Li-Wen Wang, Danika Rodrigues, Suyog Shaha, Zongmin Zhao & Samir Mitragotri. (2022) Strategies to improve the EPR effect: A mechanistic perspective and clinical translation. Journal of Controlled Release 345, pages 512-536.
Crossref
Lulu Zhang, Zhuohua Lin, Lan Zeng, Fan Zhang, Lihong Sun, Suhui Sun, Ping Wang, Menghong Xu, Jinxia Zhang, Xiaolong Liang & Huiyu Ge. (2021) Ultrasound-induced biophysical effects in controlled drug delivery. Science China Life Sciences 65:5, pages 896-908.
Crossref
Anjan Motamarry, A. Marissa Wolfe, Krishna K. Ramajayam, Sanket Pattanaik, Thomas Benton, Yuri Peterson, Pegah Faridi, Punit Prakash, Katherine Twombley & Dieter Haemmerich. (2022) Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities. Cancers 14:5, pages 1322.
Crossref
Lukas Christian Sebeke, Juan Daniel Castillo Gómez, Edwin Heijman, Pia Rademann, Alexandra Claudia Simon, Sandra Ekdawi, Susan Vlachakis, Dennis Toker, Ben Lasse Mink, Claudia Schubert-Quecke, Sin Yuin Yeo, Patrick Schmidt, Christina Lucas, Susanne Brodesser, Martin Hossann, Lars H. Lindner & Holger Grüll. (2022) Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model. Journal of Controlled Release 343, pages 798-812.
Crossref
Waad H. Abuwatfa, Nahid S. Awad, William G. Pitt & Ghaleb A. Husseini. (2022) Thermosensitive Polymers and Thermo-Responsive Liposomal Drug Delivery Systems. Polymers 14:5, pages 925.
Crossref
Natália A. D'Angelo, Mariana A. Noronha, Mayra C.C. Câmara, Isabelle S. Kurnik, Chuying Feng, Victor H.S. Araujo, João H.P.M. Santos, Valker Feitosa, João V.D. Molino, Carlota O. Rangel-Yagui, Marlus Chorilli, Emmanuel A. Ho & André M. Lopes. (2022) Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years. Biomaterials Advances 133, pages 112623.
Crossref
Adela Ademaj, Danai P. Veltsista, Pirus Ghadjar, Dietmar Marder, Eva Oberacker, Oliver J. Ott, Peter Wust, Emsad Puric, Roger A. Hälg, Susanne Rogers, Stephan Bodis, Rainer Fietkau, Hans Crezee & Oliver Riesterer. (2022) Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment. Cancers 14:3, pages 625.
Crossref
Mohammad Souri, M. Soltani, Farshad Moradi Kashkooli, Mohammad Kiani Shahvandi, Mohsen Chiani, Fatemeh Sadat Shariati, Mohammad Reza Mehrabi & Lance L. Munn. (2022) Towards principled design of cancer nanomedicine to accelerate clinical translation. Materials Today Bio 13, pages 100208.
Crossref
Yike Jiang, Ziyi Jiang, Mingzhe Wang & Lan Ma. (2022) Current understandings and clinical translation of nanomedicines for breast cancer therapy. Advanced Drug Delivery Reviews 180, pages 114034.
Crossref
A.I. Fraguas-Sanchez, C. Martin-Sabroso, A. Fernandez-Carballido & A.I. Torres-Suarez. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy 65 110 .
Nan Ji & Chalet Tan. 2022. Targeted Nanomedicine for Breast Cancer Therapy. Targeted Nanomedicine for Breast Cancer Therapy 351 368 .
Andreia Granja, Marina Pinheiro, Célia T. Sousa & Salette Reis. (2021) Gold nanostructures as mediators of hyperthermia therapies in breast cancer. Biochemical Pharmacology 190, pages 114639.
Crossref
Aleksandra Bienia, Olga Wiecheć-Cudak, Aleksandra Anna Murzyn & Martyna Krzykawska-Serda. (2021) Photodynamic Therapy and Hyperthermia in Combination Treatment—Neglected Forces in the Fight against Cancer. Pharmaceutics 13:8, pages 1147.
Crossref
Nahid S. Awad, Vinod Paul, Nour M. AlSawaftah, Gail ter HaarTheresa M. Allen, William G. Pitt & Ghaleb A. Husseini. (2021) Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review. ACS Pharmacology & Translational Science 4:2, pages 589-612.
Crossref
Marina Santiago Franco, Eliza Rocha Gomes, Marjorie Coimbra Roque & Mônica Cristina Oliveira. (2021) Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment. Frontiers in Oncology 11.
Crossref
Krishna Ramajayam, A. Wolfe, Anjan Motamarry, Georges Nahhas, John Yost, Michael Yost & Dieter Haemmerich. (2021) Untargeted Large Volume Hyperthermia Reduces Tumor Drug Uptake From Thermosensitive Liposomes. IEEE Open Journal of Engineering in Medicine and Biology 2, pages 187-197.
Crossref
Vivek Makwana, Jasmine Karanjia, Thomas Haselhorst, Shailendra Anoopkumar-Dukie & Santosh Rudrawar. (2021) Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization. International Journal of Pharmaceutics 593, pages 120117.
Crossref
Umme Ayesa & Parkson Lee-Gau Chong. (2020) Polar Lipid Fraction E from Sulfolobus acidocaldarius and Dipalmitoylphosphatidylcholine Can Form Stable yet Thermo-Sensitive Tetraether/Diester Hybrid Archaeosomes with Controlled Release Capability. International Journal of Molecular Sciences 21:21, pages 8388.
Crossref
Josanne S de Maar, Britt B M Suelmann, Manon N G J A Braat, P J van Diest, H H B Vaessen, Arjen J Witkamp, S C Linn, Chrit T W Moonen, Elsken van der Wall & Roel Deckers. (2020) Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study . BMJ Open 10:11, pages e040162.
Crossref
Mohamadreza Amin, Wenqiu Huang, Ann L. B. Seynhaeve & Timo L. M. ten Hagen. (2020) Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors. Pharmaceutics 12:11, pages 1007.
Crossref
Chae Ryeong Ahn, Jinbong Park, Jai-Eun Kim, Kwang Seok Ahn, Young Woo Kim, Minjeong Jeong, Hong Jun Kim, Sun Hyang Park & Seung Ho Baek. (2020) Cinnamaldehyde and Hyperthermia Co-Treatment Synergistically Induces ROS-Mediated Apoptosis in ACHN Renal Cell Carcinoma Cells. Biomedicines 8:9, pages 357.
Crossref
Mara Gonçalves, Serge Mignani, João Rodrigues & Helena Tomás. (2020) A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market. Journal of Controlled Release 317, pages 347-374.
Crossref
Tao Sun, Anshuman Dasgupta, Zongmin Zhao, Md Nurunnabi & Samir Mitragotri. (2020) Physical triggering strategies for drug delivery. Advanced Drug Delivery Reviews 158, pages 36-62.
Crossref
M.M. Paulides, H. Dobsicek Trefna, S. Curto & D.B. Rodrigues. (2020) Recent technological advancements in radiofrequency- andmicrowave-mediated hyperthermia for enhancing drug delivery. Advanced Drug Delivery Reviews 163-164, pages 3-18.
Crossref
A.L.B. Seynhaeve, M. Amin, D. Haemmerich, G.C. van Rhoon & T.L.M. ten Hagen. (2020) Hyperthermia and smart drug delivery systems for solid tumor therapy. Advanced Drug Delivery Reviews 163-164, pages 125-144.
Crossref
David Needham. 2020. Biomaterials for Cancer Therapeutics. Biomaterials for Cancer Therapeutics 599 723 .
Helena Besse, Angelique Barten-van Rijbroek, Kim van der Wurff-Jacobs, Clemens Bos, Chrit Moonen & Roel Deckers. (2019) Tumor Drug Distribution after Local Drug Delivery by Hyperthermia, In Vivo. Cancers 11:10, pages 1512.
Crossref
Fuyuki F. Inagaki, Aki Furusawa, Peter L. Choyke & Hisataka Kobayashi. (2019) Enhanced nanodrug delivery in tumors after near-infrared photoimmunotherapy. Nanophotonics 8:10, pages 1673-1688.
Crossref
Courtney van Ballegooie, Alice Man, Mi Win & Donald Yapp. (2019) Spatially Specific Liposomal Cancer Therapy Triggered by Clinical External Sources of Energy. Pharmaceutics 11:3, pages 125.
Crossref
Kevin A. Carter, Dandan Luo, Jumin Geng, Stephan T. Stern & Jonathan F. Lovell. (2019) Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin. Molecular Cancer Therapeutics 18:3, pages 592-601.
Crossref
Abdul K. Parchur, Jaidip M. Jagtap, Gayatri Sharma, Venkateswara Gogineni, Sarah B. White & Amit Joshi. 2019. Nanotheranostics for Cancer Applications. Nanotheranostics for Cancer Applications 429 460 .
Negar Sadeghi, Roel Deckers, Burcin Ozbakir, Sohail Akthar, Robbert Jan Kok, Twan Lammers & Gert Storm. (2018) Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes. International Journal of Pharmaceutics 548:2, pages 778-782.
Crossref
Susanne K. Golombek, Jan-Niklas May, Benjamin Theek, Lia Appold, Natascha Drude, Fabian Kiessling & Twan Lammers. (2018) Tumor targeting via EPR: Strategies to enhance patient responses. Advanced Drug Delivery Reviews 130, pages 17-38.
Crossref
Yangwei Deng, Jun Ling & Min-Hui Li. (2018) Physical stimuli-responsive liposomes and polymersomes as drug delivery vehicles based on phase transitions in the membrane. Nanoscale 10:15, pages 6781-6800.
Crossref
Dieter Haemmerich & Anjan Motamarry. 2018. Cancer Nanotechnology. Cancer Nanotechnology 121 146 .
Calvin Cheung & Wafa T. Al-Jamal. 2018. Nanooncology. Nanooncology 51 87 .
Mark W. Dewhirst & Timothy W. Secomb. (2017) Transport of drugs from blood vessels to tumour tissue. Nature Reviews Cancer 17:12, pages 738-750.
Crossref
Anjan Motamarry, Davud Asemani & Dieter Haemmerich. 2017. Liposomes. Liposomes.
Esther KneepkensEdwin HeijmanJochen KeuppSteffen WeissKlaas NicolayHolger Grüll. (2017) Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance–Guided High-Intensity Focused Ultrasound-Induced Hyperthermia. Investigative Radiology 52:10, pages 620-630.
Crossref
Judith J. Mittag, Barbara Kneidl, Tobias Preiβ, Martin Hossann, Gerhard Winter, Stefan Wuttke, Hanna Engelke & Joachim O. Rädler. (2017) Impact of plasma protein binding on cargo release by thermosensitive liposomes probed by fluorescence correlation spectroscopy. European Journal of Pharmaceutics and Biopharmaceutics 119, pages 215-223.
Crossref
Tarun Ojha, Vertika Pathak, Yang Shi, Wim E. Hennink, Chrit T.W. Moonen, Gert Storm, Fabian Kiessling & Twan Lammers. (2017) Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Advanced Drug Delivery Reviews 119, pages 44-60.
Crossref
Wouter J.M. Lokerse, Michiel Bolkestein, Simone U. Dalm, Alexander M.M. Eggermont, Marion de Jong, Holger Grüll & Gerben A. Koning. (2017) Comparing the therapeutic potential of thermosensitive liposomes and hyperthermia in two distinct subtypes of breast cancer. Journal of Controlled Release 258, pages 34-42.
Crossref
M A Zaimy, N Saffarzadeh, A Mohammadi, H Pourghadamyari, P Izadi, A Sarli, L K Moghaddam, S R Paschepari, H Azizi, S Torkamandi & J Tavakkoly-Bazzaz. (2017) New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. Cancer Gene Therapy 24:6, pages 233-243.
Crossref
Damien Mertz, Olivier Sandre & Sylvie Bégin-Colin. (2017) Drug releasing nanoplatforms activated by alternating magnetic fields. Biochimica et Biophysica Acta (BBA) - General Subjects 1861:6, pages 1617-1641.
Crossref
Marta Vicario-de-la-Torre & Jacqueline Forcada. (2017) The Potential of Stimuli-Responsive Nanogels in Drug and Active Molecule Delivery for Targeted Therapy. Gels 3:2, pages 16.
Crossref
Chang Hyun Kim, Sang Gon Lee, Myung Joo Kang, Sangkil Lee & Young Wook Choi. (2017) Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting. Journal of Pharmaceutical Investigation 47:3, pages 203-227.
Crossref
Kun He, Ping Liu & Lisa X Xu. (2017) The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response. Cell Death & Disease 8:3, pages e2703-e2703.
Crossref
Luciana Giodini, Francesco Lo Re, Davide Campagnol, Elena Marangon, Bianca Posocco, Eva Dreussi & Giuseppe Toffoli. (2017) Nanocarriers in cancer clinical practice: a pharmacokinetic issue. Nanomedicine: Nanotechnology, Biology and Medicine 13:2, pages 583-599.
Crossref
Ming Zhao, Xian-feng Ding, Jian-yu Shen, Xi-ping Zhang, Xiao-wen Ding & Bin Xu. (2017) Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice多柔比星脂质体在乳腺癌辅助化疗中的临床应用. Journal of Zhejiang University-SCIENCE B 18:1, pages 15-26.
Crossref
Dario B. Rodrigues, Paul R. Stauffer, John Eisenbrey, Valeria Beckhoff & Mark D. Hurwitz. 2017. Advances in Radiation Oncology. Advances in Radiation Oncology 69 108 .
Tanguy Boissenot, Alexandre Bordat, Elias Fattal & Nicolas Tsapis. (2016) Ultrasound-triggered drug delivery for cancer treatment using drug delivery systems: From theoretical considerations to practical applications. Journal of Controlled Release 241, pages 144-163.
Crossref
N.R. Datta, S. Krishnan, D.E. Speiser, E. Neufeld, N. Kuster, S. Bodis & H. Hofmann. (2016) Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich’s “magic (nano)bullet” for cancer theranostics?. Cancer Treatment Reviews 50, pages 217-227.
Crossref
. 2016. Drug Delivery. Drug Delivery 523 585 .
Michael Peller, Linus Willerding, Simone Limmer, Martin Hossann, Olaf Dietrich, Michael Ingrisch, Ronald Sroka & Lars H. Lindner. (2016) Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. Journal of Controlled Release 237, pages 138-146.
Crossref
Michael C Cross, Ryan G Toomey & Nathan D Gallant. (2016) Protein-surface interactions on stimuli-responsive polymeric biomaterials. Biomedical Materials 11:2, pages 022002.
Crossref
Aaron C. Anselmo & Samir Mitragotri. (2016) Nanoparticles in the clinic. Bioengineering & Translational Medicine 1:1, pages 10-29.
Crossref
Rong Tong & Daniel S. Kohane. (2016) New Strategies in Cancer Nanomedicine. Annual Review of Pharmacology and Toxicology 56:1, pages 41-57.
Crossref
Tracy Sherertz & Chris J. Diederich. 2016. Radiation Therapy Techniques and Treatment Planning for Breast Cancer. Radiation Therapy Techniques and Treatment Planning for Breast Cancer 145 158 .
Chi Hwan Lee, Hojun Kim, Daniel V Harburg, Gayoung Park, Yinji Ma, Taisong Pan, Jae Soon Kim, Na Yeon Lee, Bong Hoon Kim, Kyung-In Jang, Seung-Kyun Kang, Yonggang Huang, Jeongmin Kim, Kyung-Mi Lee, Cecilia Leal & John A Rogers. (2015) Biological lipid membranes for on-demand, wireless drug delivery from thin, bioresorbable electronic implants. NPG Asia Materials 7:11, pages e227-e227.
Crossref
ATSUKO YAMADA, SHINJI OSADA, TOSHIYUKI TANAHASHI, SATOSHI MATSUI, YOSHIYUKI SASAKI, YOSHIHIRO TANAKA, NAOKI OKUMURA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUYA YAMAGUCHI & KAZUHIRO YOSHIDA. (2015) Novel therapy for locally advanced triple-negative breast cancer. International Journal of Oncology 47:4, pages 1266-1272.
Crossref
Rong Tong & Robert Langer. (2015) Nanomedicines Targeting the Tumor Microenvironment. The Cancer Journal 21:4, pages 314-321.
Crossref
Martin Hrubý, Sergey K. Filippov & Petr Štěpánek. (2015) Smart polymers in drug delivery systems on crossroads: Which way deserves following?. European Polymer Journal 65, pages 82-97.
Crossref
Esther Tahover, Yogita P. Patil & Alberto A. Gabizon. (2015) Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index. Anti-Cancer Drugs 26:3, pages 241-258.
Crossref
Sergio Maluta & Merel Willemijn Kolff. (2015) Role of Hyperthermia in Breast Cancer Locoregional Recurrence: A Review. Breast Care 10:6, pages 408-412.
Crossref